| Description |
1 online resource |
| Series |
Protein biochemistry, synthesis, structure and cellular functions |
| Contents |
ALPHA-FETOPROTEIN FUNCTIONS AND CLINICAL APPLICATIONS; ALPHA-FETOPROTEIN FUNCTIONS AND CLINICAL APPLICATIONS; Library of Congress Cataloging-in-Publication Data; CONTENTS; FOREWORD AN OVERVIEW OF ALPHA-FETOPROTEIN RESEARCH THROUGHOUT THE DECADES; PREFACE; SECTION 1: ALPHA-FETOPROTEIN HISTORY AND NORMAL AND PATHOLOGICAL DEVELOPMENT; Chapter 1: THE HISTORY OF ALPHA-FETOPROTEIN DISCOVERY; ABSTRACT; INTRODUCTION; THE HISTORY OF ALPHA-FETOPROTEIN DISCOVERY; The First Ideas; THE MAIN SCIENTIFIC RESEARCHERS ENGAGED IN INVESTIGATION ON AFP FROM RUSSIA; INVESTIGATION ABOUT AFP IN THE WORLD |
|
MOLECULAR ANALYSES OF AFP IN LAST PERIODCONCLUSION; ACKNOWLEDGMENTS; REFERENCES; Chapter 2: ALPHA-FETOPROTEIN IN DEVELOPMENT, AFTER LIVER INJURY, DURING CHEMICAL HEPATOCARCINOGENESIS AND IN LIVER CANCER: HOW THE STUDY OF ALPHA-FETOPROTEIN LED TO THE CONCEPT OF CANCER STEM CELLS; ABSTRACT; INTRODUCTION; Radioimmunoassay for AFP; AFP in Development; AFP IN RESTITUTIVE PROLIFERATION; Partial Hepatectomy (PH); Galactosamine; Allyl Alcohol (AA); Chemical Hepatocarcinogenesis; Diethylnitrosamine (DEN); Acetylaminofluorene-CCl4; Cyclic AAF; AFP Production by Hepatomas; Function of AFP; REFERENCES |
|
Chapter 3: THE ROLE OF ALPHA-FETOPROTEIN IN HUMAN HEPATOCELLULAR CARCINOMAABSTRACT; INTRODUCTION; 1. BIOLOGICAL CHARACTERISTICS OF AFP; 1.1. Biological Functions of AFP; 2.1. AFP Is Involved in Multiple Signaling Transduction Pathways; 2. AFP IS INVOLVED IN IMMUNOSUPPRESSION PROCESS; 2.3. AFP Has Dual-Directional Regulation Effect in Cell ProliferationProcess; 3. CLINICAL USE OF AFP; REFERENCES; Chapter 4: USE OF ALPHA-FETOPROTEIN AND OTHER BIOMARKERS FOR ASSESSING HEPATOCELLULAR CARCINOMA RISK IN VIRAL HEPATITIS; ABSTRACT; INTRODUCTION |
|
ROLE OF CURRENTLY AVAILABLE BIOMARKERS AND THEIR UTILIZATION IN HCC MANAGEMENTALPHA-FETOPROTEIN; AFP for Surveillance of CHB Patients; AFP for Surveillance of Patients with Chronic Hepatitis C; AFP as Prognostic Indicator for Outcomes after the Diagnosis of HCC; AFP for Allocation of Liver Organ for Liver Transplantation; AFP-L3%; DCP; OSTEOPONTIN; GLYPICAN; GOLGI PROTEIN 73; FIBROBLAST GROWTH FACTOR (FGF) AMPLIFICATION; CANAVANINOSUCCINATE; FIVE GENE SCORE; HIGH MET EXPRESSION; CONCLUSION; REFERENCES |
|
Chapter 5: ALPHA-FETOPROTEIN IN A PROTEIN INTERACTION NETWORK: SYSTEMS BIOLOGY APPROACH IN DISCOVERY BIOMARKERS FOR HEPATOCELLULAR CARCINOMAABSTRACT; INTRODUCTION; BIOMARKER PROFILING TECHNOLOGIES; ALPHA-FETOPROTEIN IN COMBINED TESTING FOR HCC; KNOWN MOLECULAR FUNCTIONS OF HCC BIOMARKERS; EVALUABILITY OF NETWORK ANALYSIS IN HCC; CONCLUSION; REFERENCES; Chapter 6: ALPHA-FETOPROTEIN IN MALIGNANT PEDIATRIC TUMORS; ABSTRACT; INTRODUCTION; GERM CELL TUMORS; HEPATOBLASTOMA AND HEPATOCELLULAR CARCINOMA; AFP AND ASSOCIATED RARE PEDIATRIC SOLID CANCERS; CONCLUSION; REFERENCES |
| Notes |
Includes index |
|
Print version record and CIP data provided by publisher |
| Subject |
Alpha fetoproteins.
|
|
alpha-Fetoproteins
|
|
HEALTH & FITNESS -- Diseases -- General.
|
|
MEDICAL -- Clinical Medicine.
|
|
MEDICAL -- Diseases.
|
|
MEDICAL -- Evidence-Based Medicine.
|
|
MEDICAL -- Internal Medicine.
|
|
Alpha fetoproteins
|
| Form |
Electronic book
|
| Author |
Lakhi, Nisha, editor
|
|
Moretti, Michael, editor
|
| LC no. |
2016017035 |
| ISBN |
9781634849005 |
|
1634849000 |
|
